ConductScience.org, home

Paper20032295

A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties.

Navarro-Xavier RA and 5 others. J Immunol, 2010. Cited by 84 papers, by iCite.

Cite this record

ConductScience Library. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. Papers, record 20032295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20032295

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties.
PubMed
Journal
J Immunol
PubMed
Year
2010
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
84
iCite
Relative citation ratio, by iCite
2.15
iCite
Revised in PubMed
2022-03-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Navarro-Xavier RARoberta A
2Newson JJustine
3Silveira VLVera Lucia Flor
4Farrow SNStuart N
5Gilroy DWDerek W
6Bystrom JJonas

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug Delivery SystemsMajor topic
Inflammation MediatorsMajor topic
Animals
Cell Movement
Cells, Cultured
Homeostasis
Injections, Intraperitoneal
Lymphocytes
Macrophages
Mice
Mice, Inbred C57BL
Neutrophils
Peritonitis
Zymosan

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
087520Wellcome TrustUnited KingdomPubMed
Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
40977737Inhibition of IL-27 signaling regulates chemokine levels and sustains CXCR2 receptor expression on mononuclear cells to improve disease outcomes during gram-negative neonatal sepsis.Front Immunol2025https://conductscience.org/library/papers/40977737PubMed
39713922Review of methodology and re-analysis of lipidomic data focusing on specialised pro-resolution lipid mediators (SPMs) in a human model of resolving inflammation.Int J Exp Pathol2025https://conductscience.org/library/papers/39713922PubMed
39242914Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution.Nat Metab2024https://conductscience.org/library/papers/39242914PubMed
38533160Comparative Study of Azithromycin Versus Doxycycline Effect on the Resistin Level in Periodontitis Patients With Type 2 Diabetes: A Randomized Controlled Clinical Trial.Cureus2024https://conductscience.org/library/papers/38533160PubMed
37879110Stereoselective Synthesis, Pro-resolution, and Anti-inflammatory Actions of RvD5n-3 DPA.J Nat Prod2023https://conductscience.org/library/papers/37879110PubMed
37446699Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections.Molecules2023https://conductscience.org/library/papers/37446699PubMed
34897650Bruton's TK regulates myeloid cell recruitment during acute inflammation.Br J Pharmacol2022https://conductscience.org/library/papers/34897650PubMed
33995086Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.Front Pharmacol2021https://conductscience.org/library/papers/33995086PubMed
33708206Untangling Local Pro-Inflammatory, Reparative, and Regulatory Damage-Associated Molecular-Patterns (DAMPs) Pathways to Improve Transplant Outcomes.Front Immunol2021https://conductscience.org/library/papers/33708206PubMed
32757380MCTR1 enhances the resolution of lipopolysaccharide-induced lung injury through STAT6-mediated resident M2 alveolar macrophage polarization in mice.J Cell Mol Med2020https://conductscience.org/library/papers/32757380PubMed
32265698A Pro-resolving Role for Galectin-1 in Acute Inflammation.Front Pharmacol2020https://conductscience.org/library/papers/32265698PubMed
32251403Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly.Nat Immunol2020https://conductscience.org/library/papers/32251403PubMed
31613219Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation.Elife2019https://conductscience.org/library/papers/31613219PubMed
31156629Myeloid Cell and Transcriptome Signatures Associated With Inflammation Resolution in a Model of Self-Limiting Acute Brain Inflammation.Front Immunol2019https://conductscience.org/library/papers/31156629PubMed
31001110Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis.Front Pharmacol2019https://conductscience.org/library/papers/31001110PubMed
29729109Stroma: the forgotten cells of innate immune memory.Clin Exp Immunol2018https://conductscience.org/library/papers/29729109PubMed
29588627Zymosan attenuates melanoma growth progression, increases splenocyte proliferation and induces TLR-2/4 and TNF-α expression in mice.J Inflamm (Lond)2018https://conductscience.org/library/papers/29588627PubMed
28802833New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.Mol Aspects Med2018https://conductscience.org/library/papers/28802833PubMed
28336292Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.Mol Aspects Med2017https://conductscience.org/library/papers/28336292PubMed
28263773Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.Mol Aspects Med2017https://conductscience.org/library/papers/28263773PubMed

See all 55 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20032295

GET https://conductscience.org/api/papers/v1/20032295/cited_by?page=2